Alani Selvey

Title: Alani Selvey: Innovator in Neuroprotective Pharmaceuticals

Introduction

Alani Selvey is a notable inventor based in New York, NY, who has made significant contributions to the field of neuroprotective pharmaceuticals. With a total of three patents to his name, Selvey's work focuses on innovative compositions and methods that aim to treat neurodegenerative diseases.

Latest Patents

Selvey's latest patents include the development of A2-73 crystalline polymorph compositions of matter and methods of use thereof. This patent provides crystalline forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine (A2-73), in both freebase and salt forms. The disclosure also includes pharmaceutical formulations and dosage forms that utilize these crystal forms for neuroprotection, particularly in the treatment of neurodegenerative diseases. Another significant patent involves the crystal forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, detailing processes for creating these forms and their pharmaceutical compositions. This patent specifically addresses the treatment of Alzheimer's disease using polymorphic forms and metabolites of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride.

Career Highlights

Alani Selvey is currently associated with Anavex Life Sciences Corp., a company dedicated to developing innovative therapies for neurodegenerative diseases. His work has been instrumental in advancing the understanding and treatment of conditions such as Alzheimer's disease.

Collaborations

Selvey collaborates with notable colleagues, including Christopher U Missling and Linda Sharon Daintree, who contribute to the innovative research and development efforts at Anavex Life Sciences Corp.

Conclusion

Alani Selvey's contributions to neuroprotective pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His innovative work continues to pave the way for new treatments for neurodegenerative diseases.